Covered recipient · General Payments record
MARISSA DAVIDSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2024
$1,560.82
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,461.82 | 49 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $153.90 | 2 |
| Daiichi Sankyo Inc. | $143.33 | 6 |
| Incyte Corporation | $136.50 | 4 |
| BeiGene USA, Inc. | $110.00 | 1 |
| Novocure Inc. | $104.66 | 1 |
| ABBVIE INC. | $90.36 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $86.55 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $82.14 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $79.67 | 3 |
| Janssen Biotech, Inc. | $69.89 | 2 |
| PharmaEssentia USA Corporation | $60.06 | 2 |
| Acerta Pharma LLC | $56.44 | 2 |
| Regeneron Healthcare Solutions, Inc. | $52.02 | 2 |
| Exelixis Inc. | $48.77 | 2 |
| Azurity Pharmaceuticals, Inc. | $38.43 | 2 |
| Alexion Pharmaceuticals, Inc. | $29.76 | 1 |
| Immunocore Limited | $27.87 | 1 |
| EISAI INC. | $26.42 | 1 |
| PFIZER INC. | $22.57 | 1 |
| Genentech USA, Inc. | $20.84 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $20.29 | 1 |
| E.R. Squibb & Sons, L.L.C. | $18.76 | 1 |
| Mirati Therapeutics, Inc. | $18.39 | 1 |
| Janssen Pharmaceuticals, Inc | $16.63 | 1 |
| Alnylam Pharmaceuticals Inc. | $16.33 | 1 |
| Molnlycke Health Care US, LLC | $16.31 | 1 |
| Acrotech Biopharma Inc. | $13.93 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $1,560.82 | 50 |
Payment records · PY2024 (50)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.